Kiniksa Pharmaceuticals (KNSA) Financials: Revenue & Earnings
KNSA$95.18+5.98 +6.70%
$7.43B
Market Cap
62.99
P/E
69.33
Forward P/E
60
Score
Kiniksa Pharmaceuticals (KNSA) Financials: Revenue & Earnings
KNSA price $95.18 +5.98 +6.70%
- Ticker
- KNSA
- Price
- $95.18
- Change
- +5.98 +6.70%
- Market cap ?
- $7.43B
- P/E ?
- 62.99
- Forward P/E ?
- 69.33
- Dividend yield ?
- 0.00%
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Stocklytics score
- 60
- Value
- 19
- Quality
- 81
- Growth
- 81
Stocklytics score rationale: value 19, quality 81, growth 81.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 38544000 | 220180000 | 270259000 | 423239000 | 677564000 |
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an…
Fair value
KNSA fair value $43.99. Price $95.18. Price is 116% above fair value.
Above fair value, but less expensive than usual. A smaller premium than on 81% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 21.33M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 78.02M. Net debt -156.10M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2027-02-23 | — | 0.27 | — | 299.65M |
| 2026-10-27 | 0.56 | 0.37 | 285.97M | 260.66M |
| 2026-07-28 | 0.30 | 0.30 | 243.60M | 226.49M |
| 2026-04-28 | 0.27 | 0.18 | 214.27M | 206.11M |
| 2026-02-24 | 0.17 | 0.29 | 202.13M | 200.81M |
| 2025-10-28 | 0.23 | 0.33 | 180.85M | 197.09M |
| 2025-07-29 | 0.23 | 0.18 | 156.80M | 166.48M |
| 2025-04-29 | 0.11 | 0.02 | 137.78M | 131.88M |
| 2025-02-25 | -0.12 | -0.06 | 122.54M | 123.42M |
| 2024-10-29 | -0.18 | -0.02 | 112.21M | 123.38M |
| 2024-07-23 | -0.06 | -0.09 | 108.63M | 110.30M |
| 2024-04-23 | -0.25 | -0.14 | 79.86M | 78.46M |
| 2024-02-28 | 0.35 | -0.11 | 83.39M | 73.25M |
| 2023-10-31 | -0.20 | -0.18 | 67.05M | 64.45M |
| 2023-07-25 | -0.02 | -0.16 | 71.47M | 62.20M |
| 2023-05-02 | -0.18 | -0.18 | 48.34M | 46.58M |
| 2023-02-28 | 0.06 | -0.23 | 61.88M | 45.12M |
| 2022-11-01 | 3.23 | 0.47 | 99.14M | 93.58M |
| 2022-08-03 | -0.29 | -0.43 | 26.97M | 28.42M |
| 2022-05-03 | -0.36 | -0.52 | 32.19M | 30.10M |
| 2022-02-22 | -0.53 | -0.44 | 18.75M | 17.60M |
| 2021-11-01 | -0.44 | -0.63 | 12.10M | 8.78M |
| 2021-08-03 | -0.61 | -0.69 | 7.70M | 7.70M |
| 2021-05-04 | -0.72 | -0.73 | — | — |
| 2021-02-23 | -0.79 | -0.61 | — | — |
| 2020-11-05 | -0.66 | -0.59 | — | — |
| 2020-07-30 | -0.65 | -0.55 | — | — |
| 2020-04-28 | -0.48 | -0.62 | — | — |
| 2020-02-26 | -0.58 | -0.57 | — | — |
| 2019-10-28 | -0.49 | -0.74 | — | — |
| 2019-08-12 | -0.68 | -0.72 | — | — |
| 2019-05-02 | -1.27 | -0.85 | — | — |
| 2019-03-07 | -0.88 | -0.74 | — | — |
| 2018-11-01 | -0.51 | -0.50 | — | — |
| 2018-08-06 | -0.97 | -0.44 | — | — |
| 2018-05-24 | -1.01 | — | — | — |
| 2018-03-31 | -0.34 | — | — | — |
| 2017-09-30 | -0.49 | — | — | — |
| 2017-06-30 | -0.35 | — | — | — |
| 2017-03-31 | -0.15 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-03 | Megna Michael R | Sell | 4.60K | $80.30 | 369.38K |
| 2026-09-01 | Ragosa Mark | Buy | 31.15K | $79.28 | 2.47M |
| 2026-09-01 | Ragosa Mark | Buy | 3.07K | — | — |
| 2026-09-01 | Ragosa Mark | Buy | 1.59K | — | — |
| 2026-09-01 | Ragosa Mark | Sell | 4.40K | $79.28 | 349.15K |
| 2026-09-01 | Ragosa Mark | Buy | 1.75K | — | — |
| 2026-09-01 | Ragosa Mark | Buy | 2.69K | — | — |
| 2026-09-01 | Ragosa Mark | Sell | 3.07K | — | — |
| 2026-09-01 | Ragosa Mark | Buy | 7.80K | — | — |
| 2026-09-01 | Ragosa Mark | Sell | 1.59K | — | — |
| 2026-09-01 | Ragosa Mark | Sell | 1.75K | — | — |
| 2026-09-01 | Ragosa Mark | Sell | 2.69K | — | — |
| 2026-09-01 | Patel Sanj K | Buy | 120.15K | $79.28 | 9.53M |
| 2026-09-01 | Patel Sanj K | Buy | 8.61K | — | — |
| 2026-09-01 | Patel Sanj K | Buy | 6.24K | — | — |
| 2026-09-01 | Patel Sanj K | Buy | 6.48K | — | — |
| 2026-09-01 | Patel Sanj K | Sell | 15.14K | $79.28 | 1.20M |
| 2026-09-01 | Patel Sanj K | Buy | 9.99K | — | — |
| 2026-09-01 | Patel Sanj K | Buy | 30.05K | — | — |
| 2026-09-01 | Patel Sanj K | Sell | 8.61K | — | — |
| 2026-09-01 | Patel Sanj K | Sell | 6.24K | — | — |
| 2026-09-01 | Patel Sanj K | Sell | 6.48K | — | — |
| 2026-09-01 | Patel Sanj K | Sell | 9.99K | — | — |
| 2026-09-01 | Patel Sanj K | Buy | 120.15K | $79.28 | 9.53M |
| 2026-09-01 | Patel Sanj K | Buy | 8.61K | — | — |
| 2026-09-01 | Patel Sanj K | Buy | 6.24K | — | — |
| 2026-09-01 | Patel Sanj K | Buy | 6.48K | — | — |
| 2026-09-01 | Patel Sanj K | Sell | 15.14K | $79.28 | 1.20M |
| 2026-09-01 | Patel Sanj K | Buy | 9.99K | — | — |
| 2026-09-01 | Patel Sanj K | Buy | 30.05K | — | — |
| 2026-09-01 | Patel Sanj K | Sell | 8.61K | — | — |
| 2026-09-01 | Patel Sanj K | Sell | 6.24K | — | — |
| 2026-09-01 | Patel Sanj K | Sell | 6.48K | — | — |
| 2026-09-01 | Patel Sanj K | Sell | 9.99K | — | — |
| 2026-09-01 | Paolini John F. | Buy | 2.46K | — | — |
| 2026-09-01 | Paolini John F. | Buy | 1.75K | — | — |
| 2026-09-01 | Paolini John F. | Sell | 4.03K | $79.28 | 319.42K |
| 2026-09-01 | Paolini John F. | Buy | 1.62K | — | — |
| 2026-09-01 | Paolini John F. | Buy | 2.50K | — | — |
| 2026-09-01 | Paolini John F. | Buy | 26.75K | $79.28 | 2.12M |
| 2026-09-01 | Paolini John F. | Sell | 2.46K | — | — |
| 2026-09-01 | Paolini John F. | Buy | 6.70K | — | — |
| 2026-09-01 | Paolini John F. | Sell | 1.75K | — | — |
| 2026-09-01 | Paolini John F. | Sell | 1.62K | — | — |
| 2026-09-01 | Paolini John F. | Sell | 2.50K | — | — |
| 2026-09-01 | Moat Ross | Buy | 36.95K | $79.28 | 2.93M |
| 2026-09-01 | Moat Ross | Buy | 2.46K | — | — |
| 2026-09-01 | Moat Ross | Buy | 1.74K | — | — |
| 2026-09-01 | Moat Ross | Sell | 4.01K | $79.28 | 317.67K |
| 2026-09-01 | Moat Ross | Buy | 1.61K | — | — |
| 2026-09-01 | Moat Ross | Buy | 2.48K | — | — |
| 2026-09-01 | Moat Ross | Buy | 9.25K | — | — |
| 2026-09-01 | Moat Ross | Sell | 2.46K | — | — |
| 2026-09-01 | Moat Ross | Sell | 1.74K | — | — |
| 2026-09-01 | Moat Ross | Sell | 1.61K | — | — |
| 2026-09-01 | Moat Ross | Sell | 2.48K | — | — |
| 2026-09-01 | Megna Michael R | Buy | 2.64K | — | — |
| 2026-09-01 | Megna Michael R | Buy | 2.36K | — | — |
| 2026-09-01 | Megna Michael R | Buy | 2.56K | — | — |
| 2026-09-01 | Megna Michael R | Sell | 5.53K | $79.28 | 438.50K |
| 2026-09-01 | Megna Michael R | Buy | 3.93K | — | — |
| 2026-09-01 | Megna Michael R | Buy | 14.60K | $79.28 | 1.16M |
| 2026-09-01 | Megna Michael R | Sell | 2.64K | — | — |
| 2026-09-01 | Megna Michael R | Sell | 2.36K | — | — |
| 2026-09-01 | Megna Michael R | Buy | 3.65K | — | — |
| 2026-09-01 | Megna Michael R | Sell | 2.56K | — | — |
| 2026-09-01 | Megna Michael R | Sell | 3.93K | — | — |
| 2026-08-19 | Quart Barry D | Sell | 2.60K | — | — |
| 2026-08-01 | Levy Richard S | Buy | 403 | — | — |
| 2026-08-01 | Levy Richard S | Buy | 403 | — | — |
| 2026-08-01 | Levy Richard S | Sell | 403 | — | — |
| 2026-07-29 | Cole G Bradley | Sell | 3.67K | $81.43 | 299.09K |
| 2026-07-29 | Cole G Bradley | Sell | 4.50K | — | — |
| 2026-07-15 | Megna Michael R | Buy | 279 | $33.50 | 9.35K |
| 2026-07-01 | Malkani Dhiraj H | Buy | 82.60K | $62.88 | 5.19M |
| 2026-07-01 | Malkani Dhiraj H | Buy | 14.00K | — | — |
| 2026-07-01 | Malkani Dhiraj H | Buy | 2.19K | $62.88 | 137.58K |
| 2026-07-01 | Malkani Dhiraj H | Buy | 1.31K | — | — |
| 2026-06-29 | Malkani Dhiraj H | Other | 0 | — | — |
| 2026-06-01 | Patel Sanj K | Buy | 900.00K | — | — |
| 2026-06-01 | Patel Sanj K | Sell | 900.00K | — | — |
| 2026-05-29 | Quart Barry D | Buy | 2.80K | — | — |
| 2026-05-29 | Quart Barry D | Buy | 12.16K | $48.38 | 588.20K |
| 2026-05-29 | Quart Barry D | Buy | 2.03K | — | — |
| 2026-05-29 | Quart Barry D | Sell | 2.80K | — | — |
| 2026-05-29 | Popovits Kimberly J | Buy | 2.80K | — | — |
| 2026-05-29 | Popovits Kimberly J | Buy | 12.16K | $48.38 | 588.20K |
| 2026-05-29 | Popovits Kimberly J | Buy | 2.03K | — | — |
| 2026-05-29 | Popovits Kimberly J | Sell | 2.80K | — | — |
| 2026-05-29 | McCain Tracey L | Buy | 2.80K | — | — |
| 2026-05-29 | McCain Tracey L | Buy | 12.16K | $48.38 | 588.20K |
| 2026-05-29 | McCain Tracey L | Buy | 2.03K | — | — |
| 2026-05-29 | McCain Tracey L | Sell | 2.80K | — | — |
| 2026-05-29 | Malley Thomas | Buy | 2.80K | — | — |
| 2026-05-29 | Malley Thomas | Buy | 12.16K | $48.38 | 588.20K |
| 2026-05-29 | Malley Thomas | Buy | 2.03K | — | — |
| 2026-05-29 | Malley Thomas | Sell | 2.80K | — | — |
| 2026-05-29 | Levy Richard S | Buy | 2.80K | — | — |
| 2026-05-29 | Levy Richard S | Buy | 12.16K | $48.38 | 588.20K |
| 2026-05-29 | Levy Richard S | Buy | 2.03K | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 276, holders +42 vs prior quarter. Ownership 61.51%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| FMR LLC | 6.97M | 147.66K | +2.16% | 445.82M |
| RUBRIC CAPITAL MANAGEMENT LP | 4.00M | 249.80K | +6.66% | 255.79M |
| BAKER BROS. ADVISORS LP | 2.83M | 8.40K | +0.30% | 181.28M |
| BLACKROCK, INC. | 2.74M | 2.25M | +462.85% | 175.20M |
| TANG CAPITAL MANAGEMENT LLC | 2.26M | 0 | 0.00% | 144.52M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.91M | 145.07K | +8.21% | 122.23M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.36M | 27.75K | +2.08% | 87.03M |
| MORGAN STANLEY | 1.01M | 13.36K | +1.34% | 64.66M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 957.51K | 64.85K | +7.26% | 61.23M |
| SPRUCE STREET CAPITAL LP | 918.07K | 157.01K | +20.63% | 58.71M |
| DIMENSIONAL FUND ADVISORS LP | 874.79K | 62.86K | +7.74% | 55.94M |
| INVESCO LTD. | 772.81K | 772.81K | New | 49.42M |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 718.20K | 106.80K | +17.47% | 45.93M |
| STATE STREET CORP | 704.19K | 627.56K | +818.92% | 45.03M |
| ACADIAN ASSET MANAGEMENT LLC | 679.08K | -657.23K | -49.18% | 43.41M |
| POINT72 ASSET MANAGEMENT, L.P. | 659.49K | 18.54K | +2.89% | 42.17M |
| RICE HALL JAMES & ASSOCIATES, LLC | 624.93K | 16.51K | +2.71% | 39.96M |
| PICTET ASSET MANAGEMENT HOLDING SA | 608.65K | -14.64K | -2.35% | 38.92M |
| GEODE CAPITAL MANAGEMENT, LLC | 604.18K | 559.86K | +1263.22% | 38.63M |
| JUPITER TOPCO LLC | 586.18K | 586.18K | New | 37.47M |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 572.60K | -77.03K | -11.86% | 36.62M |
| D. E. SHAW & CO., INC. | 569.76K | -389.50K | -40.60% | 36.44M |
| TWO SIGMA INVESTMENTS, LP | 561.48K | 140.57K | +33.40% | 35.91M |
| VICTORY CAPITAL MANAGEMENT INC | 504.85K | -1.67K | -0.33% | 32.29M |
| SG AMERICAS SECURITIES, LLC | 504.00K | -136.18K | -21.27% | 32.23M |
Earnings and financials
Kiniksa Pharmaceuticals International, plc (KNSA) trades at $95.18, with a market cap of $7.43B and a trailing P/E of 62.99. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 38544000 | 220180000 | 270259000 | 423239000 | 677564000 |
Insights · Dividends · Forecast · Financials · Learn